What is Looxid Labs?
Looxid Labs operates at the vanguard of the neuro-technology sector, developing sophisticated AI-driven solutions that synthesize EEG and biometric data. The company's product ecosystem, which includes the Link Band 2.0 hardware and software applications like Mind Breeze and Focus Mate, provides actionable insights into cognitive states. By targeting diverse verticals such as healthcare, education, and corporate wellness, Looxid Labs addresses the increasing demand for data-backed mental health and productivity tools. Their ability to translate complex neurological signals into user-friendly applications distinguishes them within the competitive landscape of digital health and enterprise-grade wellness technology.
How much funding has Looxid Labs raised?
Looxid Labs has raised a total of $4M across 1 funding round:
Series A
$4M
Series A (2018): $4M with participation from Hastings Asset Management
Key Investors in Looxid Labs
Hastings Asset Management
A specialized investment firm focused on long-term capital appreciation and strategic growth within the technology and healthcare sectors.
What's next for Looxid Labs?
With the infusion of this latest capital, Looxid Labs is poised to accelerate its enterprise-level expansion and refine its core AI algorithms. The strategic roadmap likely involves scaling the deployment of their EEG-based hardware across clinical and corporate environments, where demand for objective cognitive health metrics is rising. As the company transitions from its current growth phase, stakeholders will be monitoring the integration of their biometric insights into broader healthcare ecosystems and the potential for new partnerships in the insurance and wellness sectors. The focus remains on solidifying their market position as a leader in neuro-adaptive technology.
See full Looxid Labs company page
